XA
XAGEW
Longevity Health Holdings, Inc.
No data for this timeframe.
Vol
Inst. Holders5 funds
Inst. Value$30.1K
Inst. Activity0 buys / 1 sells
Exchange OTC·Sector Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics·Inc. CA·CIK 0001842939
Recent Activity
Inst.
UBS Group AG — NEAR_EXIT
1,399 shares ($42.00)
Inst.
UBS Group AG — DOUBLED
12,686 shares ($279.00)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| TORONTO DOMINION BANK | $11.1K | — |
| LINDEN ADVISORS LP | $9.9K | — |
| BALYASNY ASSET MANAGEMENT L.P. | $8.0K | — |
| CITADEL ADVISORS LLC | $1.0K | — |
| UBS Group AG | $42.00 | NEAR_EXIT |
5 institutional holders with $30.1K total value (1,124,428 shares) as of 2025-Q2. Top holders: TORONTO, LINDEN, BALYASNY. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q2
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | TORONTO DOMINION BANK | 365,067 | $11.1K | 36.9% | — |
| 2 | LINDEN ADVISORS LP | 371,248 | $9.9K | 33.1% | — |
| 3 | BALYASNY ASSET MANAGEMENT L.P. | 342,706 | $8.0K | 26.4% | — |
| 4 | CITADEL ADVISORS LLC | 44,008 | $1.0K | 3.4% | — |
| 5 | UBS Group AG | 1,399 | $42.00 | 0.1% | NEAR_EXIT -89.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | NEAR_EXIT | 12,686 | 1,399 | -89.0% | $42.00 | 2025-Q2 |
| UBS Group AG | DOUBLED | 116 | 12,686 | +10836.2% | $279.00 | 2025-Q1 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 100 | 200 | +100.0% | $4.00 | 2025-Q1 |
| UBS Group AG | NEAR_EXIT | 8,976 | 116 | -98.7% | $5.00 | 2024-Q4 |
| WOLVERINE ASSET MANAGEMENT LLC | NEAR_EXIT | 4,586 | 584 | -87.3% | $35.00 | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.